Business Context and Reporting Period
This Form 6-K filing by Farmmi, Inc., a Cayman Islands corporation, covers the month of September 2021. The report details a significant capital raising event executed on September 13, 2021, involving a firm commitment public offering.
Key Financial Metrics and Transaction Details
- Offering Structure: Sale of 93,111,717 ordinary shares at $0.22 per share and 275,150,000 pre-funded warrants at $0.2199 per pre-funded warrant.
- Net Proceeds: The Company expects to receive approximately $74.2 million in net proceeds after deducting underwriting discounts and estimated offering expenses.
- Warrant Terms: Pre-funded warrants have an exercise price of $0.0001 per share and are subject to beneficial ownership limitations (4.99% or 9.99% at holder election).
- Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes
The primary material change reported is the execution of the underwriting agreement with Aegis Capital Corp. This transaction represents a substantial increase in the Company's capital base and outstanding share count compared to the prior period, though specific comparative balance sheet data is not included in this filing.
Guidance, Outlook, and Risks
Management Commentary: The Company priced the offering on September 13, 2021, following a press release on September 10, 2021, announcing the proposed offering. The securities were issued pursuant to a shelf registration statement on Form F-3 filed in March 2021.
Risks and Contingencies: The filing notes that the summary of the Underwriting Agreement and Warrant Agent Agreement is subject to the full text of these documents filed as exhibits. No specific operational risks or forward-looking guidance regarding future earnings were detailed in this specific text.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received versus the estimated $74.2 million.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific underwriting discounts and expense allocations.
- Examine the Warrant Agent Agreement (Exhibit 4.1) for detailed terms regarding the pre-funded warrants and exercise mechanics.
- Confirm the impact of the new share issuance on existing shareholder dilution and beneficial ownership percentages.
- Check subsequent filings for the use of proceeds and any changes in the Company's liquidity position post-offering.